About Medicinal Genomics
Medicinal Genomics is a company based in Woburn (United States) founded in 2011 was acquired by Courtagen in January 2012.. Medicinal Genomics has raised $7.69 million across 2 funding rounds from investors including Courtagen. Medicinal Genomics offers products and services including PathoSEEK® qPCR Detection Assays, MaGiC Lysis Kits, FemINDICAtor® qPCR Plant Gender Detection Assay, and SenSATIVAx® DNA Purification Kits. Medicinal Genomics operates in a competitive market with competitors including Benson Hill, Cibus, Pairwise, Inari and Ceres, among others.
- Headquarter Woburn, United States
-
Sectors
HealthcareAgriculture
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Medicinal Genomics Corps
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Medicinal Genomics
Medicinal Genomics offers a comprehensive portfolio of products and services, including PathoSEEK® qPCR Detection Assays, MaGiC Lysis Kits, FemINDICAtor® qPCR Plant Gender Detection Assay, and SenSATIVAx® DNA Purification Kits. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Detects pathogens in cannabis plants using qPCR technology.
Prepares samples for genomic analysis in plant testing.
Identifies plant gender early to optimize breeding processes.
Purifies DNA for accurate microbial and genetic testing.
Unlock access to complete
Sales and Marketing
4 people
Operations Team
2 people
Leadership Team
2 people
Finance and Accounting
1 people
Unlock access to complete
Funding Insights of Medicinal Genomics
Medicinal Genomics has successfully raised a total of $7.69M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.68 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $2.7M
-
First Round
First Round
(02 Nov 2017)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2021 | Amount | Series A - Medicinal Genomics | Valuation |
investors |
|
| Nov, 2017 | Amount | Series A - Medicinal Genomics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Medicinal Genomics
Medicinal Genomics has secured backing from 1 investor. Prominent investors backing the company include Courtagen. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provides solutions for neurological and metabolic disorders.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Medicinal Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Medicinal Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Medicinal Genomics Comparisons
Competitors of Medicinal Genomics
Medicinal Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Benson Hill, Cibus, Pairwise, Inari and Ceres, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of plant-based food ingredients
|
|
| domain | founded_year | HQ Location |
Gene editing solutions are provided for agriculture.
|
|
| domain | founded_year | HQ Location |
New crop varieties are developed using gene-editing for agrigenomics.
|
|
| domain | founded_year | HQ Location |
Breeding technology is provided by Inari to design seeds.
|
|
| domain | founded_year | HQ Location |
Beers are produced and branded by Ceres in Italy.
|
|
| domain | founded_year | HQ Location |
Developer of a predictive breeding platform to identify crop traits and build crop models
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Medicinal Genomics
Frequently Asked Questions about Medicinal Genomics
When was Medicinal Genomics founded?
Medicinal Genomics was founded in 2011 and raised its 1st funding round 6 years after it was founded.
Where is Medicinal Genomics located?
Medicinal Genomics is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Is Medicinal Genomics a funded company?
Medicinal Genomics is a funded company, having raised a total of $7.69M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Nov 02, 2017.
What does Medicinal Genomics do?
Medicinal Genomics was founded in 2011 and is based in Woburn, United States. Cannabis sequencing services are offered, including a DNA database for the plant. Fingerprinting assays are planned, encompassing DNA purification, gender testing, and microbial testing. These support strain genotyping and sequencing for development in the genomics sector.
Who are the top competitors of Medicinal Genomics?
Medicinal Genomics's top competitors include Benson Hill, Cibus and Inari.
What products or services does Medicinal Genomics offer?
Medicinal Genomics offers PathoSEEK® qPCR Detection Assays, MaGiC Lysis Kits, FemINDICAtor® qPCR Plant Gender Detection Assay, and SenSATIVAx® DNA Purification Kits.
Who are Medicinal Genomics's investors?
Medicinal Genomics has 1 investor. Key investors include Courtagen.